Novonix (NVX) Current Deferred Revenue (2020 - 2025)
Novonix (NVX) has 6 years of Current Deferred Revenue data on record, last reported at $146475.0 in Q4 2025.
- For Q4 2025, Current Deferred Revenue rose 16.2% year-over-year to $146475.0; the TTM value through Dec 2025 reached $146475.0, up 16.2%, while the annual FY2025 figure was $146475.0, 16.2% up from the prior year.
- Current Deferred Revenue reached $146475.0 in Q4 2025 per NVX's latest filing, up from $126056.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $285221.0 in Q4 2023 and bottomed at $2820.7 in Q2 2022.
- Average Current Deferred Revenue over 5 years is $145225.6, with a median of $136265.5 recorded in 2024.
- Peak YoY movement for Current Deferred Revenue: tumbled 98.82% in 2022, then soared 296.22% in 2023.
- A 5-year view of Current Deferred Revenue shows it stood at $238795.6 in 2021, then plummeted by 69.85% to $71985.0 in 2022, then skyrocketed by 296.22% to $285221.0 in 2023, then plummeted by 55.8% to $126056.0 in 2024, then grew by 16.2% to $146475.0 in 2025.
- Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $146475.0 in Q4 2025, $126056.0 in Q4 2024, and $285221.0 in Q4 2023.